Article Details

On November, 8 Coherus BioSciences, Inc. (CHRS) Analysts See $-0.79 EPS

Retrieved on: 2018-10-25 21:07:30

Tags for this article:

Click the tags to see associated articles and topics

On November, 8 Coherus BioSciences, Inc. (CHRS) Analysts See $-0.79 EPS. View article details on hiswai:

Excerpt

<div><b>Kohlberg Kravis Roberts</b> Comm Ltd Partnership holds 0.49% or 3.06M shs. Coherus BioSciences, Inc. (NASDAQ:CHRS)'s quarterly earnings will be ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up